Background/Aims: Tumor necrosis factor-α (TNF-α) inhibitors and ustekunimab are widely used in autoimmune diseases. It is known that these biological agents cause the reactivation of hepatitis B virus (HBV). There is no standardized strategy to prevent the reactivation in patients with evidence of a previous HBV infection. In our study, anti-HBc IgG-positive patients who received a biological agent were evaluated in terms of HBV reactivation. Materials and Methods: Patients who were followed up for the use of biological agents in our clinic were evaluated retrospectively. Patients with isolated anti-HBc IgG positivity were included in the study. The HBV reactivation data were recorded from the patients’ files retrospectively. Results: Two hundred and seventy-eight patients who received biological treatment were evaluated. Twenty-nine patients with isolated anti-HBc IgG positivity or resolved HBV infection were included in the study. The HBV reactivation was seen in 5 patients (17.2%). Of these patients, 3 were using adalimumab, 1 infliximab, and 1 ustekunimab. It was controlled by antiviral therapy that was started in the early period. Conclusion: Drugs that block TNF-α and ustekunimab cause an increase in viral replication. In literature, the HBV reactivation rate was approximately 1% in HBsAg-negative, anti-HBC IgG-positive cases, whereas it was found to be as high as 17.2% in our study. Patients receiving the immunomodulator therapy should be evaluated for HBV serology before treatment and carefully monitored for HBV reactivation during and after treatment. Cite this article as: Solay AH, Acar A, Eser F, et al. Reactivation rates in patients using biological agents, with resolved HBV infection or isolated anti-HBc IgG positivity. Turk J Gastroenterol 2018; 29: 561-5.
Differentiating tuberculous spondylodiscitis (TS) from pyogenic spondylodiscitis (PS) is challenging due to overlapping clinical and radiological features.
Introduction: Brucellosis is a zoonotic disease distributed worldwide and very important public health problem especially in the developing countries. In this study, we aimed to evaluate the clinical/laboratory findings of brucellosis patients and contribute of coombs testing to diagnosis at Iğdır State Hospital infection diseases and clinical microbiology department. Materials and Methods: One hundred and forty-five brucellosis patients followed up in our clinic between September 2012 and February 2013 were evaluated retrospectively. Demographic characteristics, laboratory findings, diagnostic methods of the patients were presented. Results: The mean age of the patients were 39±15 (18-80) and 59% (n=86) of the patients were female, 41% (n=59) were male. Most frequent risk factors were animal breeding (n=115, 79%) and using underdone milk and milk products (n=98, 69%). Most reported complaints were weakness (92%), arthralgia (89%), sweating (74%), lack of appetite (70%) and fever (68%). Fifty-seven of the brucellosis patients could not diagnosed with standard tube agglutination. Therefore, Coombs test was used for these undiagnosed patients (39%, n=57). Eighty patients were evaluated as acute (55%), 53 as subacute (37%) and 12 as chronic (8%) brucellosis. Conclusions: Brucellosis can affect all organ systems and cause different clinical manifestations. Therefore, difficulties are encountered in the diagnosis of the disease. Brucellosis should be kept in mind in the differential diagnosis especially in the endemic regions. When the clinical suspicion exists detailed laboratory evaluation must be performed.
28 November 2022 in Turkish Journal of Intensive Care
Amaç: Kateter ilişkili üriner enfeksiyon, sağlık tesislerinden hastalara geçen en yaygın enfeksiyonlardandır. Üriner kateterlerin doğru yerleştirilmesi ve bakımı enfeksiyon kontrol uygulamalarında önemli bir konudur. Çalışmada yıllara göre kateter ilişkili üriner sistem enfeksiyonu (ÜSİ-KAT) oranlarının değişimi ve eğitimin etkisinin vurgulanması amaçlanmıştır. Gereç ve Yöntem: 2016-2018 yılları arasında yapılan bu çalışmada, anestezi/reanimasyon yoğun bakım ünitesinde ve dahiliye yoğun bakım ünitesinde takip edilen hastaların sürveyans verileri kullanıldı. Verilerin incelendiği dönemde anestezi/reanimasyon yoğun bakım ünitesinde (YBÜ) bulunan 3,399 hasta ile YBÜ bulunan 1,207 hasta takip edildi. Kliniklerde yapılan fiziki değişikliklerin ve eğitimlerin ÜSİ-KAT oranları üzerindeki etkileri araştırıldı. Bulgular: Dahiliye ve anestezi/reanimasyon YBÜ’lerinde 2016-2018 yıllarında yapılan değişiklikler sonucunda, ÜSİ-KAT hızlarında belirgin düşme olduğu görüldü. Her iki ünitede 2016 yılında ÜSİ-KAT hızı Türkiye ortalamasının üzerinde iken 2018 yılında yapılan değişikliklerin sonucunda ÜSİ-KAT hızlarının Türkiye ortalamasının altına düştüğü görüldü. Sonuç: YBÜ'lerde invaziv araç kullanımına bağlı gelişen enfeksiyonların önlenmesinde, hasta ve bakteri özelliklerinin bilinmesinin yanı sıra; personel eğitimleri, denetimler ve enfeksiyon kontrol komitesinin yoğun bakım ekibi ile iş birliği içinde olması önem arz etmektedir.